Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Biopharma Inc (NASDAQ:TBPH)

40.75
Delayed Data
As of 3:59pm ET
 +0.82 / +2.05%
Today’s Change
15.00
Today|||52-Week Range
40.90
+27.82%
Year-to-Date
No recent news for Theravance Biopharma Inc.

Today’s Trading

Previous close39.93
Today’s open39.98
Day’s range39.84 - 40.90
Volume203,195
Average volume (3 months)243,968
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)+20.22%
Earnings growth (this year)-6.48%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)+15.48%
P/E ratioNM
Price/Sales29.30
Price/Book6.02

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...-0.94-1.71%
PTLAPortola Pharmaceutic...-0.86-2.17%
LGNDLigand Pharmaceutica...+0.51+0.47%
SRPTSarepta Therapeutics...-0.95-2.65%
Data as of 3:59pm ET, 04/26/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$1.11
Annual revenue (last year)$48.6M
Annual profit (last year)-$190.7M
Net profit margin-391.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Senior VP &
Global Head-Acute Care Business
Frank C. Pasqualone
Corporate headquarters
George Town, George Town

Forecasts


Search for Jobs